Busting the billion-dollar myth: how to slash the cost of drug development

Amy Maxmen
Additional contact information
Amy Maxmen: Amy Maxmen is a science journalist in Berkeley, California.

Nature, 2016, vol. 536, issue 7617, 388-390

Abstract: A non-profit organization is proving that new drugs don't have to cost a fortune. Can its model work more broadly?

Date: 2016
References: Add references at CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
https://www.nature.com/articles/536388a Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:536:y:2016:i:7617:d:10.1038_536388a

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/536388a

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().